PHOENIX, AZ -- (Marketwired) -- 08/17/15 -- Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ: INSY) today announced that the New Drug Application (NDA) for its proprietary Dronabinol Oral Solution has been accepted for filing by the U.S. Food and Drug Administration ( ...
↧